FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to conjugates of Disorazol with cell adhesion molecules, such as peptides, proteins, hormones, blood proteins, and methods for preparing conjugates.
EFFECT: conjugates of Disorazol may be used as drug preparations for treating various tumours.
19 cl, 17 dwg, 2 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATES, CONTAINING HYDROPHILIC SPACERS OF LINKERS | 2008 |
|
RU2523909C2 |
| POLY-LIGAND MEDICINAL CONJUGATES AND USE THEREOF | 2016 |
|
RU2722449C2 |
| CONJUGATES OF LIGAND AND DRUGS | 2006 |
|
RU2470668C2 |
| CHEMICAL LINKERS AND CONJUGATES THEREOF | 2005 |
|
RU2402548C2 |
| TARGETED CONJUGATES AND PARTICLES AND COMPOSITIONS THEREOF | 2015 |
|
RU2695220C2 |
| COVALENT LINKERS IN ANTIBODY-DRUG CONJUGATES, METHODS FOR PREPARING THEM AND USE THEREOF | 2016 |
|
RU2698727C1 |
| MODULE MOLECULAR CONJUGATE FOR TARGETING GENETIC CONSTRUCTS AND METHOD FOR PREPARING IT | 2012 |
|
RU2529034C2 |
| MONOMETHYLVALINE COMPOUNDS CAPABLE OF FORMING CONJUGATES WITH LIGANDS | 2004 |
|
RU2448117C2 |
| BOMBESIN ANALOGUE PEPTIDE ANTAGONIST CONJUGATES | 2009 |
|
RU2523531C2 |
| PROTEIN-POLYMER-DRUG CONJUGATES | 2012 |
|
RU2617402C2 |
